Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mouse gut metagenome

ABSTRACT: Study of Intestinal microbiota in graft-versus-host disease

PROVIDER: PRJDB4167 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR067308_1.fastq.gz	Fastqsanger.gz
	DRR067308_2.fastq.gz	Fastqsanger.gz
	DRR067309_1.fastq.gz	Fastqsanger.gz
	DRR067309_2.fastq.gz	Fastqsanger.gz
	DRR067310_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 192

Similar Datasets

mouse gut metagenome (410661)

Project description:Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity

| PRJNA980199 | ENA

mouse gut metagenome

Project description:Impacts of Intestinal microbiota on graft-versus-host disease and engraftment after hematopoietic stem cell transplant

| PRJDB5102 | ENA

gut metagenome

Project description:Fecal microbiota transplantations reconstitute gut fungal and viral microbiota in graft-versus-host disease

| PRJNA515137 | ENA

gut metagenome

Project description:Metagenomic next-generation sequencing of Graft-versus-Host disease

| PRJNA396964 | ENA

human gut metagenome

Project description:Fecal microbiota transplantation for the gastrointestinal steroid-refractory graft-versus host disease using frozen capsule.

| PRJDB7070 | ENA

Project description:Bacteroides ovatus alleviates dysbiotic microbiota induced intestinal graft-versus-host disease

| PRJNA973955 | ENA

Project description:Intestinal Microbiota Controls Graft-versus-Host Disease Independent of Donor-Host Genetic Disparity

| PRJNA979931 | ENA

Gut-microbiota derived N,N,N-trimethyl-5-aminovaleric acid (TMAVA) is a modulator of CNS-aGVHD

Project description:In this study, we report that microbiota depletion results in exacerbated acute graft-vs-host disease in the central nervous system (CNS), mediated by microglia activation and T-cell infiltration. We could rescue the inflammatory changes in the CNS by administering the microbiota-derived metabolite N,N,N-trimethyl-5-aminovalerate.

2024-11-14 | MSV000096417 | MassIVE

The effect of LCN2 treatment on anti-inflammatory bone marrow derived macrophages

Project description:Allogeneic hematopoietic stem cell transplantation remains the most efficacious treatment for many hematological malignancies. However, its therapeutic potential is affected by the most prominent side effect graft versus host disease. Despite advances in the treatment of graft versus host disease in recent years, morbidity and mortality remains high, which requires the development of new treatment approaches. We therefore implemented mouse models to assess potential treatment options for graft versus host disease. In in vivo experiments, we had observed a protective effect of LCN2 on graft versus host disease of the gastrointestinal tract. We also observed higher numbers of anti-inflammatory macrophages in the intestinal tissues of these animals. Therefore, we aimed to determine potentially regulated genes in these cells by using an in vitro approach of LCN2-treated macrophages.

2024-01-24 | GSE226432 | GEO

human feces metagenome (2705415)

Project description:Stool microbiota and Graft versus Host Disease after Hematopoietic Cell Transplantation

| PRJNA1052666 | ENA